<?xml version="1.0" encoding="UTF-8"?>
<p>Furthermore, naringenin administration in HCD rats exhibits significant improvements in serum levels of nitric oxide, LDH, oxidative damage markers of lipids, and lipid profile [
 <xref rid="B119-plants-09-01784" ref-type="bibr">119</xref>]. Naringenin was found to reduce the chances of atherosclerosis by alleviating dyslipidemia and insulin resistance, thereby inhibiting the assembly of apolipoprotein B100. Studies have also shown that naringenin increases fatty acid oxidation and blocks cholesterol synthesis and esterification, which results in reduced hepatic triglycerides and decreases cholesteryl ester; thus, there is a limited secretion of VLDL [
 <xref rid="B145-plants-09-01784" ref-type="bibr">145</xref>].
</p>
